[Argentine Consensus of Congenital Toxoplasmosis].
The mother-to-child transmission in Toxoplasma gondii infection occurs only when the infection is acquired for the first time during pregnancy. The prenatal and early postnatal diagnosis can only be achieved by serological testing. Serologic tests have different sensitivities, specificities and complexities, so that different tests in more than one blood sample are necessary for the diagnosis. Serological follow-up of the infants should be conducted during the first year of life or until the diagnosis of congenital toxoplasmosis can be ruled out. Treatment recommendations try to reduce the transmission rate and the risk of congenital damage. Congenital toxoplasmosis incidence rate is approximately 5 per 1000 births, but can be reduced to 0.5 per 1000 with an active screening program. The aim of this consensus group was to review the scientific literature on congenital toxoplasmosis and prepare a statement on prevention, diagnosis and treatment that should be implemented in our country.
Durlach
Ricardo
R
Asociación Argentina de Zoonosis. rdurlach@hospitalaleman.com
Kaufer
Federico
F
Carral
Liliana
L
Freuler
Cristina
C
Ceriotto
Mariana
M
Rodriguez
Marcelo
M
Freilij
Hector
H
Altcheh
Jaime
J
Vazquez
Liliana
L
Corazza
Rosana
R
Dalla Fontana
Maria
M
Arienti
Hector
H
Sturba
Edgardo
E
Gonzalez Ayala
Silvia
S
Cecchini
Emilio
E
Salomon
Cristina
C
Nadal
Monica
M
Gutierrez
Nestor
N
Guarnera
Eduardo
E
D000913:Antibodies, Protozoan / Q000097:blood; D001118:Argentina; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D018445:Infectious Disease Transmission, Vertical / Q000517:prevention & control*; D008403:Mass Screening; D015997:Neonatal Screening; D011247:Pregnancy; D015597:Pregnancy Complications, Parasitic / Q000175:diagnosis / Q000517:prevention & control / Q000628:therapy; D011296:Prenatal Diagnosis; D012307:Risk Factors; D014125:Toxoplasmosis, Congenital / Q000175:diagnosis / Q000628:therapy / Q000635:transmission
D000913:Antibodies, Protozoan